Telomerase activity in endoscopically visible lung cancer

Anticancer Research

Volumn 21, Issue 5, 2001, Pages 3685-3689

  Hirashima, Tomonori ^a   Yoshitaka, Ogata ^a   Nitta, Takashi ^a   Sasada, Shinji ^a   Kobayashi, Masashi ^a   Masuda, Noriyuki ^a   Matsui, Kaoru ^a   Nakagawa, Katsuhiro ^a   Yasumitsu, Tsutomu ^a   Takada, Yoshiaki ^a   Kikui, Masanori ^a   Kawase, Ichiro ^a  

^a OSAKA PREFECTURAL MEDICAL CENTER FOR RESPIRATORY AND ALLERGIC DISEASES   (Japan)

Author keywords

Fiberoptic bronchoscopy; Lung cancer; Telomerase activity

Indexed keywords

TELOMERASE;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; ENDOSCOPY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; BRONCHOSCOPY; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; TELOMERASE;

EID: 0035571077     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Telomere length predicts replicative capacity of human fibroblasts
2. Specific association of human telomerase activity with immortal cells and cancer
3. Telomerase activity in small cell and non-small cell lung cancer
4. Telomerase activity in lung cancer cells obtained from bronchial washings
5. Telomerase: A potential marker of bladder transitional cell carcinoma in bladder washes
6. Telomerase activity in lesions of the thyroid: Application to diagnosis of clinical samples including fine-needle aspirates
7. Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer
8. Hammerhead ribozyme-mediated inhibition of telomerase activity in extracts of human hepatocellular carcinoma cells
9. Inhibition of human telomerase activity by peptide nucleic acids
10. Effects of reverse transcriptase inhibitors on Telomere length and telomerse activity in two immortalized human cell lines
11. Preclinical and clinical strategies for development of telomerase and telomere inhibitors
12. Antitelomerase therapy suppressed glioma proliferation
13. Inhibition of telomerase limits the growth of human cancer cells
14. Revisions in the international system for staging lung cancer
15. Telomere crisis, the driving force in cancer cell evolution
16. Prognostic significance of telomeric repeat length alterations in pathological stage I-IIIA non-small cell lung cancer
17. Telomerase elongation in immortal human cells without detectable telomerase activity
18. High telomerase activity in primary lung cancers: Association with increased cell proliferation rates and advanced pathologic stage